Sexual function recovery after robot-assisted radical prostatectomy: Outcomes from an Italian referral centre and predicting nomogram.


Journal

Andrologia
ISSN: 1439-0272
Titre abrégé: Andrologia
Pays: Germany
ID NLM: 0423506

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 16 05 2019
revised: 20 06 2019
accepted: 10 07 2019
pubmed: 20 8 2019
medline: 3 4 2020
entrez: 20 8 2019
Statut: ppublish

Résumé

Aims of this study were to assess sexual recovery after robotic-assisted radical prostatectomy (RARP) and to build a nomogram predicting 1-year sexual function. From May 2015 to July 2016, all patients eligible for RARP at our institution were invited to enter the study. The Expanded Prostate cancer Index Composite (EPIC) questionnaire was administered pre-operatively, then at 45 days, and at 3, 6, 9, and 12 months post-operatively. According to sexual function scores, patients were divided into four classes. Multivariate analysis was used to investigate the influence of patient- and disease-related features on sexual recovery. A total of 643 patients were included. Age was associated with baseline potency (p < .0001). Bioptic Gleason score (GS; p = .0002), American Society of Anesthesiologists (ASA) score ( = .002ASA Physical Status Classification System ) and Charlson Comorbidity Index (CCI; p = .02) were negatively associated with potency. Baseline sexual function was associated with potency recovery. A nomogram resulted from fitting a proportional odds logistic model for ordinal outcomes, with 1-year sexual function as a dependent variable and baseline sexual potency, age, body mass index (BMI), clinical stage, biopsy GS, initial prostate-specific antigen (iPSA), ASA score, and CCI as predictors. After further validation, this nomogram could be a useful tool for the pre-operative counselling.

Identifiants

pubmed: 31423619
doi: 10.1111/and.13385
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13385

Informations de copyright

© 2019 Blackwell Verlag GmbH.

Références

Alemozaffar, M., Regan, M. M., Cooperberg, M. R., Wei, J. T., Michalski, J. M., Sandler, H. M., … Sanda, M. G. (2011). Prediction of erectile function following treatment for prostate cancer. JAMA, 306(11), 1205-1214. https://doi.org/10.1001/jama.2011.1333
Alemozaffar, M., Sanda, M., Yecies, D., Mucci, L. A., Stampfer, M. J., & Kenfield, S. A. (2015). Benchmarks for operative outcomes of robotic and open radical prostatectomy: Results from the Health Professionals Follow-up Study. European Urology, 67(3), 432-438. https://doi.org/10.1016/j.eururo.2014.01.039
ASA Physical Status Classification System. Retrieved from http://www.frca.co.uk/article.aspx?articlexml:id=100184
Associazione Italiana dei Registri TUMori. Retrieved from http://itacan.ispo.toscana.it/italian/StatsFact.asp?cancer=291&country=39000
Bianchi, R., Cozzi, G., Petralia, G., Alessi, S., Renne, G., Bottero, D., … De Cobelli, O. (2016). Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy. Medicine (Baltimore), 95(40), e4519. https://doi.org/10.1097/MD.0000000000004519
Bianco, F. J. Jr, Scardino, P. T., & Eastham, J. A. (2005). Radical prostatectomy: Long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology, 66(5 Suppl), 83-94. https://doi.org/10.1016/j.urology.2005.06.116
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., … Johansson, J.-E. (2011). Radical prostatectomy versus watchful waiting in early prostate cancer. New England Journal of Medicine, 364(18), 1708-1717. https://doi.org/10.1056/NEJMoa1011967
Briganti, A., Gallina, A., Suardi, N., Capitanio, U., Tutolo, M., Bianchi, M., … Montorsi, F. (2010). Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: A proposal of a novel preoperative risk stratification. The Journal of Sexual Medicine, 7(7), 2521-2531. https://doi.org/10.1111/j.1743-6109.2010.01845.x
Burnett, A. L., Aus, G., Canby-Hagino, E. D., Cookson, M. S., D'Amico, A. V., Dmochowski, R. R., … Thompson, I. (2007). Erectile function outcome reporting after clinically localized prostate cancer treatment. Journal of Urology, 178(2), 597-601. https://doi.org/10.1016/j.juro.2007.03.140
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373-383. https://doi.org/10.1016/0021-9681(87)90171-8
Deveci, S., Gotto, G. T., Alex, B., O'Brien, K., & Mulhall, J. P. (2016). A survey of patient expectations regarding sexual function following radical prostatectomy. BJU International, 118(4), 641-645. https://doi.org/10.1111/bju.13398
Eastham, J. A., Scardino, P. T., & Kattan, M. W. (2008). Predicting an optimal outcome after radical prostatectomy: The trifecta nomogram. Journal of Urology, 179(6), 2207-2210; discussion 2210-2201. https://doi.org/10.1016/j.juro.2008.01.106
Esserman, L., Shieh, Y., & Thompson, I. (2009). Rethinking screening for breast cancer and prostate cancer. JAMA, 302(15), 1685-1692. https://doi.org/10.1001/jama.2009.1498
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., … Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359-E386. https://doi.org/10.1002/ijc.29210
Ficarra, V., Novara, G., Ahlering, T. E., Costello, A., Eastham, J. A., Graefen, M., … Montorsi, F. (2012). Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. European Urology, 62(3), 418-430. https://doi.org/10.1016/j.eururo.2012.05.046
Gandaglia, G., Suardi, N., Gallina, A., Zaffuto, E., Cucchiara, V., Vizziello, D., … Briganti, A. (2014). How to optimize patient selection for robot-assisted radical prostatectomy: Functional outcome analyses from a tertiary referral center. Journal of Endourology, 28(7), 792-800. https://doi.org/10.1089/end.2014.0007
Harrell, F. E. Jr, Califf, R. M., Pryor, D. B., Lee, K. L., & Rosati, R. A. (1982). Evaluating the yield of medical tests. JAMA, 247(18), 2543-2546. https://doi.org/10.1001/jama.1982.03320430047030
Harrell, F. E. Jr, Lee, K. L., & Mark, D. B. (1996). Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine, 15(4), 361-387. https://doi.org/10.1002/(SICI)1097-0258(19960229)15:4<361:AID-SIM168>3.0.CO;2-4
Haskins, A. E., Han, P. K., Lucas, F. L., Bristol, I., & Hansen, M. (2014). Development of clinical models for predicting erectile function after localized prostate cancer treatment. International Journal of Urology, 21(12), 1227-1233. https://doi.org/10.1111/iju.12566
Herlemann, A., Cowan, J. E., Carroll, P. R., & Cooperberg, M. R. (2018). Community-based outcomes of open versus robot-assisted radical prostatectomy. European Urology, 73(2), 215-223. https://doi.org/10.1016/j.eururo.2017.04.027
Kilminster, S., Muller, S., Menon, M., Joseph, J. V., Ralph, D. J., & Patel, H. R. (2012). Predicting erectile function outcome in men after radical prostatectomy for prostate cancer. BJU International, 110(3), 422-426. https://doi.org/10.1111/j.1464-410X.2011.10757.x
KleinJan, G. H., Sikorska, K., Korne, C. M., Brouwer, O. R., Buckle, T., Tillier, C., … van der Poel, H. G. (2018). A prediction model relating the extent of intraoperative fascia preservation to erectile dysfunction after nerve-sparing robot-assisted radical prostatectomy. Journal of Robotic Surgery, 13(3), 455-462. https://doi.org/10.1007/s11701-018-0867-5
Lee, Z., Lightfoot, A. J., Mucksavage, P., & Lee, D. I. (2015). Can robot-assisted radical prostatectomy be taught to chief residents and fellows without affecting operative outcomes? Prostate International, 3(2), 47-50. https://doi.org/10.1016/j.prnil.2015.03.005
Loppenberg, B., von Bodman, C., Brock, M., Roghmann, F., Noldus, J., & Palisaar, R. J. (2014). Effect of perioperative complications and functional outcomes on health-related quality of life after radical prostatectomy. Quality of Life Research, 23(10), 2743-2756. https://doi.org/10.1007/s11136-014-0729-1
Mirone, V., Costa, P., Damber, J. E., Holmes, S., Moncada, I., Van Ahlen, H., … Varanese, L. (2005). An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries. European Urology, 47(6), 846-854; discussion 854. https://doi.org/10.1016/j.eururo.2005.02.019
Montorsi, F., Brock, G., Stolzenburg, J.-U., Mulhall, J., Moncada, I., Patel, H. R. H., … Büttner, H. (2014). Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: A randomised placebo-controlled study (REACTT). European Urology, 65(3), 587-596. https://doi.org/10.1016/j.eururo.2013.09.051
Patel, V. R., Sandri, M., Grasso, A. A. C., De Lorenzis, E., Palmisano, F., Albo, G., … Rocco, B. (2018). A novel tool for predicting extracapsular extension during graded partial nerve sparing in radical prostatectomy. BJU International, 121(3), 373-382. https://doi.org/10.1111/bju.14026
Patel, V. R., Sivaraman, A., Coelho, R. F., Chauhan, S., Palmer, K. J., Orvieto, M. A., … Rocco, B. (2011). Pentafecta: A new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. European Urology, 59(5), 702-707. https://doi.org/10.1016/j.eururo.2011.01.032
Tasci, A. I., Tufek, I., Gumus, E., Canda, A. E., Tugcu, V., Atug, F., … Kural, A. R. (2015). Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: Multicenter experience in Turkey including 1,499 patients. World Journal of Urology, 33(8), 1095-1102. https://doi.org/10.1007/s00345-014-1393-3
Tholomier, C., Bienz, M., Hueber, P.-A., Trinh, Q. D., Hakim, A. E., Alhathal, N., … Zorn, K. C. (2014). Oncological and functional outcomes of 722 robot-assisted radical prostatectomy (RARP) cases: The largest Canadian 5-year experience. Canadian Urological Association Journal, 8(5-6), 195-201. https://doi.org/10.5489/cuaj.2016
van der Poel, H. G., & de Blok, W. (2009). Role of extent of fascia preservation and erectile function after robot-assisted laparoscopic prostatectomy. Urology, 73(4), 816-821. https://doi.org/10.1016/j.urology.2008.09.082
Wheat, J. C., Hedgepeth, R. C., He, C., Zhang, L., & Wood, D. P. Jr (2009). Clinical interpretation of the Expanded Prostate cancer Index Composite-short form sexual summary score. Journal of Urology, 182(6), 2844-2849. https://doi.org/10.1016/j.juro.2009.08.088
Willis, D. L., Gonzalgo, M. L., Brotzman, M., Feng, Z., Trock, B., & Su, L. M. (2012). Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: A study of comparative effectiveness based upon validated quality of life outcomes. BJU International, 109(6), 898-905. https://doi.org/10.1111/j.1464-410X.2011.10551.x
Wilt, T. J., Brawer, M. K., Jones, K. M., Barry, M. J., Aronson, W. J., & Fox, S. … Prostate Cancer Intervention versus Observation Trial Study Group (2012). Radical prostatectomy versus observation for localized prostate cancer. New England Journal of Medicine, 367(3), 203-213. https://doi.org/10.1056/NEJMoa1113162
Xu, T., Wang, X., Xia, L., Zhang, X., Qin, L., Zhong, S., & Shen, Z. (2015). Robot-assisted prostatectomy in obese patients: How influential is obesity on operative outcomes? Journal of Endourology, 29(2), 198-208. https://doi.org/10.1089/end.2014.0354

Auteurs

Gabriele Cozzi (G)

Division of Urology, European Institute of Oncology, IRCCS, Milan, Italy.

Gennaro Musi (G)

Division of Urology, European Institute of Oncology, IRCCS, Milan, Italy.

Massimo Monturano (M)

Risk Management Service, European Institute of Oncology, IRCCS, Milan, Italy.

Vincenzo Bagnardi (V)

Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.

Samuele Frassoni (S)

Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.

Barbara A Jereczek-Fossa (BA)

Division of Radiotherapy, European Institute of Oncology, IRCCS, Milan, Italy.
Università Degli Studi Di Milano, Milan, Italy.

Matteo Ferro (M)

Division of Urology, European Institute of Oncology, IRCCS, Milan, Italy.

Roberto Bianchi (R)

Division of Urology, European Institute of Oncology, IRCCS, Milan, Italy.

Francesco A Mistretta (FA)

Division of Urology, European Institute of Oncology, IRCCS, Milan, Italy.
Università Degli Studi Di Milano, Milan, Italy.

Ottavio de Cobelli (O)

Division of Urology, European Institute of Oncology, IRCCS, Milan, Italy.
Università Degli Studi Di Milano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH